Company Profile
Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom, the United States, and internationally. The company operates in three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. It offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products. The company also provides sports medicine joint repair products comprise instruments, technologies, and implants to perform minimally invasive surgery, as well as treating soft tissue injuries and degenerative conditions of the shoulder, knee, hip, and small joints. In addition, it provides arthroscopic enabling technologies comprising fluid management equipment for surgical access, cameras, digital image capture, scopes, light sources, and monitors to assist with visualization inside the joints, radio frequency, electromechanical and mechanical tissue resection devices, and hand instruments for removing damaged tissue; and ear, nose, and throat solutions. Further, the company offers advanced wound care products for the treatment and prevention of acute and chronic wounds, leg, diabetic and pressure ulcers, burns, and post-operative wounds; advanced wound bioactives, such as biologics and other bioactive technologies for debridement and dermal repair/regeneration, and regenerative medicine products, including skin, bone graft, and articular cartilage substitutes; and advanced wound devices, such as traditional and single-use negative pressure wound therapy, and hydrosurgery systems. It serves the healthcare providers. Smith & Nephew plc was founded in 1856 and is headquartered in Watford, the United Kingdom.
Latest News
Smith+Nephew Expands ASC Platform to Support Value-Based Care
European Equities Traded in the US as American Depositary Receipts Rise in Friday Trading
Smith+Nephew introduces expanded enterprise ASC Solutions Strategy to support growth, performance and value-based care
Smith+Nephew Launches LYNX COBLATION Wand for ENT Airway Surgery
Homes with a View: SNN Raj Bay Vista introduces 'Work from Nature' Concept in the Heart of South Bengaluru with Lake Facing Homes
| Sector | Healthcare |
| Industry | Medical Devices |
| Website | https://www.smith-nephew.com |
| Market Cap | 12.86B |
| Trailing P/E | 21.38 |
| Forward P/E | 13.39 |
| Dividend Rate | 0.78 |
| Dividend Yield | 2.56% |
| Trailing Annual Div. Rate | 0.39 |
| Trailing Annual Div. Yield | 1.31% |
| Trailing EPS | 1.43 |
| Forward EPS | 2.28 |
| Book Value | 2.49 |
| Price-to-Book | 12.27 |
| Enterprise-to-Revenue | 10.98 |
| Enterprise-to-EBITDA | 50.66 |
| Short Ratio | 2.93 |
| Ex-Dividend Date | 03/27/2026 |
| Dividend Date | 05/27/2026 |
| Earnings Date | 08/04/2026 |
| Earnings Call Date | 08/04/2026 |
| Revenue Average | 1.48B |
| Revenue Low | 1.48B |
| Revenue High | 1.48B |